Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis
- 1 April 2007
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 9 (4) , 483-489
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Leukotriene B4Strongly Increases Monocyte Chemoattractant Protein-1 in Human MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Leukotriene B4 receptor BLT1 mediates early effector T cell recruitmentNature Immunology, 2003
- Role of Trehalose Dimycolate in Recruitment of Cells and Modulation of Production of Cytokines and NO in TuberculosisInfection and Immunity, 2001
- Leukotriene B4Augments Neutrophil Phagocytosis ofKlebsiella pneumoniaeInfection and Immunity, 2001
- Enhancement of CD4+ T‐cell‐dependent interleukin‐2 production in vitro by murine alveolar macrophages: the role of leukotriene B4Immunology, 1997
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.Journal of Experimental Medicine, 1993
- Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration “in vivo” by indirect mechanismsInflammation Research, 1990
- Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.Journal of Experimental Medicine, 1989
- Leukotriene B: a potential mediator of inflammationJournal of Pharmacy and Pharmacology, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980